301 related articles for article (PubMed ID: 27601021)
1. Changes of serum sclerostin and Dickkopf-1 levels during the menstrual cycle. A pilot study.
Liakou CG; Mastorakos G; Makris K; Fatouros IG; Avloniti A; Marketos H; Antoniou JD; Galanos A; Dontas I; Rizos D; Tournis S
Endocrine; 2016 Nov; 54(2):543-551. PubMed ID: 27601021
[TBL] [Abstract][Full Text] [Related]
2. Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial.
Anastasilakis AD; Polyzos SA; Gkiomisi A; Bisbinas I; Gerou S; Makras P
J Clin Endocrinol Metab; 2013 Aug; 98(8):3206-12. PubMed ID: 23788684
[TBL] [Abstract][Full Text] [Related]
3. Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone.
Idolazzi L; Fassio A; Tripi G; Braga V; Viapiana O; Adami G; Rossini M; Gatti D
Clin Rheumatol; 2017 Apr; 36(4):925-928. PubMed ID: 28054306
[TBL] [Abstract][Full Text] [Related]
4. Serum sclerostin levels associated with lumbar spine bone mineral density and bone turnover markers in patients with postmenopausal osteoporosis.
Xu XJ; Shen L; Yang YP; Lu FR; Zhu R; Shuai B; Li CG; Wu MX
Chin Med J (Engl); 2013 Jul; 126(13):2480-4. PubMed ID: 23823821
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant tamoxifen but not aromatase inhibitor therapy decreases serum levels of the Wnt inhibitor dickkopf-1 while not affecting sclerostin in breast cancer patients.
Göbel A; Kuhlmann JD; Link T; Wimberger P; Browne AJ; Rauner M; Hofbauer LC; Rachner TD
Breast Cancer Res Treat; 2017 Aug; 164(3):737-743. PubMed ID: 28526959
[TBL] [Abstract][Full Text] [Related]
6. Effects of sex steroids on serum sclerostin levels during the menstrual cycle.
Cidem M; Usta TA; Karacan I; Kucuk SH; Uludag M; Gun K
Gynecol Obstet Invest; 2013; 75(3):179-84. PubMed ID: 23429230
[TBL] [Abstract][Full Text] [Related]
7. Effect of glucocorticoid treatment on Wnt signalling antagonists (sclerostin and Dkk-1) and their relationship with bone turnover.
Gifre L; Ruiz-Gaspà S; Monegal A; Nomdedeu B; Filella X; Guañabens N; Peris P
Bone; 2013 Nov; 57(1):272-6. PubMed ID: 23981659
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels of dickkopf-1, osteoprotegerin and sclerostin are higher in old compared with young men and women and positively associated with whole-body bone mineral density in older adults.
Coulson J; Bagley L; Barnouin Y; Bradburn S; Butler-Browne G; Gapeyeva H; Hogrel JY; Maden-Wilkinson T; Maier AB; Meskers C; Murgatroyd C; Narici M; Pääsuke M; Sassano L; Sipilä S; Al-Shanti N; Stenroth L; Jones DA; McPhee JS
Osteoporos Int; 2017 Sep; 28(9):2683-2689. PubMed ID: 28585053
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with serum soluble inhibitors of Wnt-β-catenin signaling (sclerostin and dickkopf-1) in patients undergoing peritoneal dialysis.
Yamada S; Tsuruya K; Tokumoto M; Yoshida H; Ooboshi H; Kitazono T
Nephrology (Carlton); 2015 Sep; 20(9):639-45. PubMed ID: 25974190
[TBL] [Abstract][Full Text] [Related]
10. Early effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis.
Terpos E; Fragiadaki K; Konsta M; Bratengeier C; Papatheodorou A; Sfikakis PP
Clin Exp Rheumatol; 2011; 29(6):921-5. PubMed ID: 22032557
[TBL] [Abstract][Full Text] [Related]
11. Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease.
Polyzos SA; Anastasilakis AD; Kountouras J; Makras P; Papatheodorou A; Kokkoris P; Sakellariou GT; Terpos E
J Bone Miner Metab; 2016 Jul; 34(4):447-56. PubMed ID: 26056025
[TBL] [Abstract][Full Text] [Related]
12. Bone Sclerostin and Dickkopf-related protein-1 are positively correlated with bone mineral density, bone microarchitecture, and bone strength in postmenopausal osteoporosis.
Peng J; Dong Z; Hui Z; Aifei W; Lianfu D; Youjia X
BMC Musculoskelet Disord; 2021 May; 22(1):480. PubMed ID: 34034718
[TBL] [Abstract][Full Text] [Related]
13. Bone turnover marker profile in relation to the menstrual cycle of premenopausal healthy women.
Gass ML; Kagan R; Kohles JD; Martens MG
Menopause; 2008; 15(4 Pt 1):667-75. PubMed ID: 18327152
[TBL] [Abstract][Full Text] [Related]
14. Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis.
Gatti D; Viapiana O; Idolazzi L; Fracassi E; Ionescu C; Dartizio C; Troplini S; Kunnathully V; Adami S; Rossini M
Bone; 2014 Oct; 67():189-92. PubMed ID: 25003812
[TBL] [Abstract][Full Text] [Related]
15. The waning of teriparatide effect on bone formation markers in postmenopausal osteoporosis is associated with increasing serum levels of DKK1.
Gatti D; Viapiana O; Idolazzi L; Fracassi E; Rossini M; Adami S
J Clin Endocrinol Metab; 2011 May; 96(5):1555-9. PubMed ID: 21367927
[TBL] [Abstract][Full Text] [Related]
16. Sclerostin and DKK1 in primary hyperparathyroidism.
Viapiana O; Fracassi E; Troplini S; Idolazzi L; Rossini M; Adami S; Gatti D
Calcif Tissue Int; 2013 Apr; 92(4):324-9. PubMed ID: 23430197
[TBL] [Abstract][Full Text] [Related]
17. Zoledronic acid acutely increases sclerostin serum levels in women with postmenopausal osteoporosis.
Catalano A; Morabito N; Basile G; Brancatelli S; Cucinotta D; Lasco A
J Clin Endocrinol Metab; 2013 May; 98(5):1911-5. PubMed ID: 23596142
[TBL] [Abstract][Full Text] [Related]
18. Preeclampsia - a risk factor for osteoporosis? Analysis of maternal Sclerostin levels and markers of bone turnover in patients with pre-eclampsia.
Wild J; Pateisky P; Küssel L; Huf W; Ott J; Haslinger P; Knöfler M; Zeisler H
Hypertens Pregnancy; 2014 Aug; 33(3):333-40. PubMed ID: 24568269
[TBL] [Abstract][Full Text] [Related]
19. High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: the Center of Excellence for Osteoporosis Research Study.
Ardawi MS; Rouzi AA; Al-Sibiani SA; Al-Senani NS; Qari MH; Mousa SA
J Bone Miner Res; 2012 Dec; 27(12):2592-602. PubMed ID: 22836717
[TBL] [Abstract][Full Text] [Related]
20. Circulating sclerostin levels and markers of bone turnover in Chinese-American and white women.
Costa AG; Walker MD; Zhang CA; Cremers S; Dworakowski E; McMahon DJ; Liu G; Bilezikian JP
J Clin Endocrinol Metab; 2013 Dec; 98(12):4736-43. PubMed ID: 24037879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]